Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Are the counters correct? If so, WOW
View:
Post by cashascars on Jan 18, 2022 3:07pm

Are the counters correct? If so, WOW

I've never seen anywhere on Stockhouse the amount of reads showing on TLT Bullboard. If the counter is displaying correctly, the amount of interest in this company is beyond any other that came before it. 700 or more reads is not uncommon today.
When the interest turns into investors we will see huge gains, bringing this company to a Market Cap it deserves. With a 2 treatment process to cure Bladder cancer and no serious discomfort or side affects, with many more potential cancer targets to come. My thoughts of a proper Market Cap is Much Much higher than present, all we need is more positive results from our phase 2 and in my optomistic view they are on thier way shortly so don't miss out on the move up into the dollars, now is the time to strike or pay more later. 
Again I'm a little over the top some times with my opinions but correct me if I'm way out please.
cashascars
Comment by DJDawg on Jan 18, 2022 3:10pm
cool. where are these counters that you speak of?
Comment by cashascars on Jan 18, 2022 3:14pm
When you open the post, just look to the right of the post opposite the writers name. cashascars
Comment by CancerSlayer on Jan 18, 2022 3:56pm
  cashascars...for a car salesman, you're actually on point ; ).  By offering a better ACT option for a finite number of cancers (the superficial/accessible tumors), the MC would certainly be in the tens of billions.  An even bigger goldmine imo needs to be unleashed in the form effective/efficient treatment of interstitial or deep-seated cancers (I.e. via x-ray activation). & ...more  
Comment by StevenBirch on Jan 18, 2022 4:35pm
I don't know where this goes if we get good numbers in the upcoming quarterly update and BTD shortly after but I don't think it's $0.60 - $0.80 more likely $3 to $4. If that happens more and more people will begin to see it as still dirt cheap in the grand scheme of things. There are just too many people looking at this, probably nibbling but waiting to pile in when those who are ...more  
Comment by Pandora on Jan 18, 2022 5:34pm
Yes, I can remember that happening to me back in the 1999 - 2000 tech bubble time (22 years ago?) only to see most of it disappear again a year or so later in the bubble burst era of 2001. Such is life in the market -- ups and downs. Could certainly use more ups to try and even out the downs. :-))
Comment by Eoganacht on Jan 18, 2022 6:49pm
Plus there is the prospect of an immune response after treatment and this response is not necessarily restricted to treatment of superficial/accessible tumors. If Theralase's pdt ends up not being a stand-alone treatment for every type of cancer there is also the possibility of use as an adjuvant treatment such as in the intra-operative pdt for NSCLC that Roswell Park considered before ...more  
Comment by CancerSlayer on Jan 18, 2022 10:36pm
Thanks for your response...the body's immune response certainly adds another level of treatment & protection to readily accessible tumors.  To clarify, I was simply suggesting that the body's immune response to PDT may be dampened or wane more rapidly for certain "treated" tumors that are larger, more complex in structure, or simply less responsive/accessible to an ...more  
Comment by CancerSlayer on Jan 19, 2022 12:50am
..."the body's immune response certainly adds another level of treatment & protection to readily accessible tumors." ....against   Note:  "to" can also be considered correct usage of the word when used (as I intended) in reference to "the treatment" of accessible tumors....darn English language.  Btw, I now figured out why my posts get so ...more  
Comment by thadeush on Jan 18, 2022 10:19pm
I agree with everything you are saying about TLT, but be wary of giving much weight to the number of reads, or anything on SH for that matter. People are excited about there finally being some movement in the stock. Some (I know I have) have read good posts multiple times. But what happens on this board has virtually zero effect on the stock price. We are an echo chamber of TLT enthusiasts ...more  
Comment by CancerSlayer on Jan 18, 2022 11:19pm
Large but tough audience...I may not be a Canadian, but I'm a strong TLT believer & self-proclaimed TLT realist ; )    
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250